Did COVID Change Biotech Funding for Good?

As we all know, the COVID-19 pandemic required pharmaceutical companies to put to the test how fast vaccines, treatments, and diagnostics could be developed, tested, and implemented on a large scale. With this wave of need in the biotech sector, investments in biotech...

Why We Invested: Prelude

A game-changing alternative in the death care industry Author: Matt Waraich, Cortado Ventures Investment Associate Cortado Ventures has always taken pride in pioneering innovative thinking and investment strategies. Our aim is not to just stand out from the crowd, but...

Why We Invested: Fluid Efficiency

Cortado Ventures is thrilled to have recently invested in Fluid Efficiency, a California-based polymer materials company focused on the oil and gas industry. The company is part of the EIC Rose Rock Bridge Program and is setting up their large-scale manufacturing...